One More Extension for DESI Estrogen-Androgen Fixed Combination Drug Products
Today, notice of the third extension of the “final” DESI notice appeared on the Federal Register pre-publication page here. The first “final” notice (which was published in May 2026) “concluded that all outstanding hearing requests for estrogen-androgen fixed-combination drug products under Docket FDA-1998-P-0083 had been withdrawn, and that such products lack substantial evidence of effectiveness […]

